Logo image of BLCO

BAUSCH + LOMB CORP (BLCO) Stock Fundamental Analysis

NYSE:BLCO - New York Stock Exchange, Inc. - CA0717051076 - Common Stock - Currency: USD

16.22  -0.08 (-0.49%)

Fundamental Rating

2

Overall BLCO gets a fundamental rating of 2 out of 10. We evaluated BLCO against 190 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of BLCO while its profitability can be described as average. BLCO has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year BLCO was profitable.
In the past year BLCO had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: BLCO reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: BLCO reported negative operating cash flow in multiple years.
BLCO Yearly Net Income VS EBIT VS OCF VS FCFBLCO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 200M -200M 400M 600M 800M

1.2 Ratios

BLCO has a Return On Assets of -2.72%. This is in the better half of the industry: BLCO outperforms 65.96% of its industry peers.
Looking at the Return On Equity, with a value of -5.59%, BLCO is in the better half of the industry, outperforming 67.02% of the companies in the same industry.
With a decent Return On Invested Capital value of 1.28%, BLCO is doing good in the industry, outperforming 68.09% of the companies in the same industry.
BLCO had an Average Return On Invested Capital over the past 3 years of 2.06%. This is significantly below the industry average of 8.14%.
Industry RankSector Rank
ROA -2.72%
ROE -5.59%
ROIC 1.28%
ROA(3y)-0.07%
ROA(5y)0.45%
ROE(3y)-0.59%
ROE(5y)0.21%
ROIC(3y)2.06%
ROIC(5y)2.3%
BLCO Yearly ROA, ROE, ROICBLCO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 2 -2

1.3 Margins

BLCO's Operating Margin of 4.06% is fine compared to the rest of the industry. BLCO outperforms 70.74% of its industry peers.
In the last couple of years the Operating Margin of BLCO has declined.
BLCO has a better Gross Margin (60.89%) than 60.11% of its industry peers.
BLCO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 4.06%
PM (TTM) N/A
GM 60.89%
OM growth 3Y-13.3%
OM growth 5Y-16.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.05%
GM growth 5Y-1.21%
BLCO Yearly Profit, Operating, Gross MarginsBLCO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 20 40 60

More info and screens

1

2. Health

2.1 Basic Checks

BLCO has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
BLCO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BLCO Yearly Shares OutstandingBLCO Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 100M 200M 300M
BLCO Yearly Total Debt VS Total AssetsBLCO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2B 4B 6B 8B 10B

2.2 Solvency

BLCO has an Altman-Z score of 0.92. This is a bad value and indicates that BLCO is not financially healthy and even has some risk of bankruptcy.
BLCO has a Altman-Z score of 0.92. This is comparable to the rest of the industry: BLCO outperforms 49.47% of its industry peers.
BLCO has a Debt/Equity ratio of 0.70. This is a neutral value indicating BLCO is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.70, BLCO is not doing good in the industry: 70.74% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF N/A
Altman-Z 0.92
ROIC/WACC0.16
WACC8.08%
BLCO Yearly LT Debt VS Equity VS FCFBLCO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 2B 4B 6B 8B

2.3 Liquidity

BLCO has a Current Ratio of 1.57. This is a normal value and indicates that BLCO is financially healthy and should not expect problems in meeting its short term obligations.
BLCO has a Current ratio of 1.57. This is in the lower half of the industry: BLCO underperforms 75.00% of its industry peers.
A Quick Ratio of 0.95 indicates that BLCO may have some problems paying its short term obligations.
BLCO has a worse Quick ratio (0.95) than 80.85% of its industry peers.
Industry RankSector Rank
Current Ratio 1.57
Quick Ratio 0.95
BLCO Yearly Current Assets VS Current LiabilitesBLCO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 500M 1B 1.5B 2B 2.5B

More info and screens

2

3. Growth

3.1 Past

The earnings per share for BLCO have decreased strongly by -16.22% in the last year.
EPS 1Y (TTM)-16.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%4.17%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%9.12%

3.2 Future

Based on estimates for the next years, BLCO will show a very strong growth in Earnings Per Share. The EPS will grow by 27.21% on average per year.
Based on estimates for the next years, BLCO will show a small growth in Revenue. The Revenue will grow by 4.44% on average per year.
EPS Next Y29.89%
EPS Next 2Y30.3%
EPS Next 3Y31.59%
EPS Next 5Y27.21%
Revenue Next Year5.47%
Revenue Next 2Y5.65%
Revenue Next 3Y5.28%
Revenue Next 5Y4.44%

3.3 Evolution

BLCO Yearly Revenue VS EstimatesBLCO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B
BLCO Yearly EPS VS EstimatesBLCO Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0.5 1 1.5 2 2.5

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 26.16, which means the current valuation is very expensive for BLCO.
79.79% of the companies in the same industry are more expensive than BLCO, based on the Price/Earnings ratio.
BLCO's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 30.42.
With a Price/Forward Earnings ratio of 20.14, BLCO is valued on the expensive side.
82.98% of the companies in the same industry are more expensive than BLCO, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.75, BLCO is valued at the same level.
Industry RankSector Rank
PE 26.16
Fwd PE 20.14
BLCO Price Earnings VS Forward Price EarningsBLCO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BLCO indicates a rather cheap valuation: BLCO is cheaper than 84.04% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.79
BLCO Per share dataBLCO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BLCO's earnings are expected to grow with 31.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.88
PEG (5Y)N/A
EPS Next 2Y30.3%
EPS Next 3Y31.59%

More info and screens

0

5. Dividend

5.1 Amount

BLCO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BAUSCH + LOMB CORP

NYSE:BLCO (2/20/2025, 3:04:58 PM)

16.22

-0.08 (-0.49%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-19 2025-02-19/bmo
Earnings (Next)N/A N/A
Inst Owners11.91%
Inst Owner Change-6%
Ins Owners0.29%
Ins Owner Change-5.59%
Market Cap5.72B
Analysts73
Price Target21.03 (29.65%)
Short Float %4.23%
Short Ratio2.84
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.43%
Min EPS beat(2)4.19%
Max EPS beat(2)6.68%
EPS beat(4)3
Avg EPS beat(4)11.18%
Min EPS beat(4)-5.47%
Max EPS beat(4)39.31%
EPS beat(8)6
Avg EPS beat(8)7.15%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.92%
Min Revenue beat(2)-0.08%
Max Revenue beat(2)1.93%
Revenue beat(4)3
Avg Revenue beat(4)1.8%
Min Revenue beat(4)-0.08%
Max Revenue beat(4)3.9%
Revenue beat(8)6
Avg Revenue beat(8)1.93%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.46%
PT rev (3m)0.5%
EPS NQ rev (1m)-2.23%
EPS NQ rev (3m)-1.89%
EPS NY rev (1m)-1.66%
EPS NY rev (3m)-0.82%
Revenue NQ rev (1m)-0.08%
Revenue NQ rev (3m)-0.08%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)-0.12%
Valuation
Industry RankSector Rank
PE 26.16
Fwd PE 20.14
P/S 1.22
P/FCF N/A
P/OCF 25.41
P/B 0.87
P/tB N/A
EV/EBITDA 15.79
EPS(TTM)0.62
EY3.82%
EPS(NY)0.81
Fwd EY4.97%
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)0.64
OCFY3.94%
SpS13.29
BVpS18.69
TBVpS-3.9
PEG (NY)0.88
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.72%
ROE -5.59%
ROCE 1.62%
ROIC 1.28%
ROICexc 1.32%
ROICexgc 4.39%
OM 4.06%
PM (TTM) N/A
GM 60.89%
FCFM N/A
ROA(3y)-0.07%
ROA(5y)0.45%
ROE(3y)-0.59%
ROE(5y)0.21%
ROIC(3y)2.06%
ROIC(5y)2.3%
ROICexc(3y)2.11%
ROICexc(5y)2.36%
ROICexgc(3y)7.21%
ROICexgc(5y)8.24%
ROCE(3y)2.6%
ROCE(5y)2.92%
ROICexcg growth 3Y-12.27%
ROICexcg growth 5YN/A
ROICexc growth 3Y-11.43%
ROICexc growth 5YN/A
OM growth 3Y-13.3%
OM growth 5Y-16.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.05%
GM growth 5Y-1.21%
F-Score4
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF N/A
Debt/EBITDA 7.23
Cap/Depr 63.45%
Cap/Sales 6.04%
Interest Coverage 250
Cash Conversion 35.38%
Profit Quality N/A
Current Ratio 1.57
Quick Ratio 0.95
Altman-Z 0.92
F-Score4
WACC8.08%
ROIC/WACC0.16
Cap/Depr(3y)46.69%
Cap/Depr(5y)47.14%
Cap/Sales(3y)4.71%
Cap/Sales(5y)5.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%4.17%
EPS Next Y29.89%
EPS Next 2Y30.3%
EPS Next 3Y31.59%
EPS Next 5Y27.21%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%9.12%
Revenue Next Year5.47%
Revenue Next 2Y5.65%
Revenue Next 3Y5.28%
Revenue Next 5Y4.44%
EBIT growth 1Y-5%
EBIT growth 3Y-7.49%
EBIT growth 5Y-14.12%
EBIT Next Year80.4%
EBIT Next 3Y29.3%
EBIT Next 5Y18.66%
FCF growth 1Y-136.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-35.34%
OCF growth 3YN/A
OCF growth 5YN/A